Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of delirium in inpatients with advanced cancer
ACTRN12612000931875Phase 2Completed
- Sponsor
- Flinders University
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in delirium comparing Melatonin with Placebo (2 arms). Primary endpoint: Feasibility and acceptability. Started Jul 2014; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12612000931875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000931875.